chartexchange

Clarity Pharmaceuticals Hits SECuRE Cohort Expansion Main Group Recruitment Target

Small Caps | Oct 7, 2026 10:18 PM EDT

Clarity Pharmaceuticals hits SECuRE main-group recruitment target, advancing its prostate cancer therapy trial as Phase III planning gets underway.

Read original article